Chembio Diagnostics

Chembio Diagnostics Debt

Delisted

The Debt of Chembio Diagnostics (CEMI) as of Oct 29, 2026 is 18.74 M USD. In the previous year, Debt was 19.00 M USD — a change of -1.34% (lower).

Debt

18.74 MUSD

YoY

-1.34%

Last updated:

In 2022, Chembio Diagnostics's total debt was 18.74 M USD, a -1.34% change from the 19.00 M USD total debt recorded in the previous year.

The Chembio Diagnostics Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
100,000.00 USD
Jan 1, 2018
380,000.00 USD
Jan 1, 2019
18.04 M USD
Jan 1, 2020
18.43 M USD
Jan 1, 2021
19.00 M USD
Jan 1, 2022
18.74 M USD
The Chembio Diagnostics Debt history
YEARDebtYoY
18.74 MUSD-1.34%
19.00 MUSD+3.08%
18.43 MUSD+2.16%
18.04 MUSD+4,647.37%
380,000.00USD+280.00%
100,000.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Chembio Diagnostics Stock analysis

What does Chembio Diagnostics do? Chembio Diagnostics Inc is a biomedical company specializing in the development and commercialization of diagnostic test kits. The company was founded in 1985 and is headquartered in Medford, New York. Chembio Diagnostics is one of the most popular companies on Eulerpool.

Debt Details

Understanding Chembio Diagnostics's Debt Structure

Chembio Diagnostics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Chembio Diagnostics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Chembio Diagnostics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Chembio Diagnostics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Chembio Diagnostics stock

Debt of Chembio Diagnostics is 18.74 M USD in 2022.

Debt of Chembio Diagnostics changed from 19.00 M USD to 18.74 M USD, representing a -1.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Chembio Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Chembio Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Chembio Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Chembio Diagnostics